About Dr. Morepen Limited
Data last updated:
Dr. Morepen Limited is a public limited company based in New Delhi, Delhi, India, a subsidiary of Morepen Laboratories Limited. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 11 July 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2001PLC111636. Its GSTIN is 07AABCD4166G1ZT (Delhi). The company holds 18 GST registrations, of which 14 are active.
The company has an authorised share capital of ₹131 Cr and a paid-up capital of ₹127.25 Cr. It was formerly known as Doctor Morepen Limited. It is led by directors including Varun Suri (Managing Director) and Sharad Jain.
Its last annual general meeting (AGM) was held on 06 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 409 Antriksh Bhawan 22 K.G. Marg, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2025, the company reported a revenue of ₹170.92 Cr, a growth of 81% compared to the previous year. For the same year it recorded a net profit of ₹10.01 Cr (net margin 5.9%) and EBITDA of ₹14.87 Cr (EBITDA margin 8.7%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 21% over five years.
The company has about 231 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹88 Lakh and satisfied charges of ₹11.18 Cr on record. Court records list 209 cases involving the company, including 182 filed by the company and 25 filed against it; 62 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website morepen.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address409 Antriksh Bhawan 22 K.G. Marg, New Delhi, Delhi, India – 110001
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dr. Morepen Limited
The main business activity of Dr. Morepen is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dr. Morepen Limited FY 2025 filings available
Dr. Morepen Limited reported revenue of ₹170.92 Cr (up 81% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dr. Morepen Limited
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 81% growth in the latest year. EBITDA rose 361% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dr. Morepen Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹14.87 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹10.01 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dr. Morepen Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dr. Morepen are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dr. Morepen Limited
Dr. Morepen Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anzen Exports Private Limited | ₹173.73 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Kolkata, West Bengal, India |
| Dhanvanthri Speciality Pharma Private Limited | ₹172.95 Cr (FY 2024) | •••• | •••• | 41.0% | •••• | Bangalore, Karnataka, India |
| Medsource Healthcare Private Limited | ₹172.66 Cr (FY 2019) | •••• | •••• | -40.0% | •••• | New Delhi, Delhi, India |
| Farmachem Life Private Limited | ₹171.18 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Mumbai, Maharashtra, India |
| Goa Medicos Private Limited | ₹171.03 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Gurgaon, Haryana, India |
| Dr. Morepen Limited this company | ₹170.92 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | New Delhi, Delhi, India |
| Advanced Sterilization Products India Private Limited | ₹170.85 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Mumbai, Maharashtra, India |
| Utivac Healthcare Private Limited | ₹168.34 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Bangalore, Karnataka, India |
| Espee Pharma Chem Private Limited | ₹168.11 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Ahmedabad, Gujarat, India |
| Yashodaplus Pharmacies India Private Limited | ₹168.11 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Grownbury Pharmaceuticals Private Limited | ₹167.88 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Dr. Morepen by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dr. Morepen Limited
Dr. Morepen Limited is audited by S.P BABUTA & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S.P BABUTA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dr. Morepen Limited
Dr. Morepen has 4 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aakriti Suri | Additional Director | 14 Nov 2025 | 0 Years 11 Months | Current |
| Varun Suri | Managing Director | 11 Nov 2021 | 4 Years 11 Months | Current |
| Sharad Jain Also directs: Morepen Laboratories Limited | Director | 27 Aug 2024 | 2 Years 1 Months | Current |
| Ranjit Khattar Also directs: Xpress Funding Advisors LLP, Morepen Laboratories Limited, Eldeco Sohna Projects Limited and 5 more | Director | 12 Aug 2024 | 2 Years 2 Months | Current |
Ownership and Shareholding of Dr. Morepen Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dr. Morepen Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 May 2015 | Bmw India Financial Services Private Limited | ₹44 Lakh | Satisfied |
| 18 May 2015 | Bmw India Financial Services Private Limited | ₹44 Lakh | Satisfied |
| 09 Aug 2006 | Lakshmi Vilas Bank Limited | ₹10.3 Cr | Satisfied |
Total charge records: 3 View all charges
Legal Cases of Dr. Morepen Limited
Dr. Morepen Limited has 209 court cases on record: 182 filed by Dr. Morepen, 25 filed against it, 2 where it is another party. 62 cases are pending and 147 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 176 | 11 | 55 |
| High courts | 33 | 14 | 7 |
Cases on record (5 of 209)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against Saveo Healthtech Private Limited | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against Growtouch Pharma Private Limited | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against Krirudraa Pharma Private Limited | Pending |
| District court, East, Delhi | Court case (Civ Suit) | Filed by the company against Gurunath Pharma Private Limited | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Godrej Consumer Products Limited | Pending |
Full case history
All 209 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Dr. Morepen Limited
Dr. Morepen Limited has a workforce of 231 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Dr. Morepen Limited
Dr. Morepen has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Total Care Limited | U24246DL2000PLC105296 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on Dr. Morepen Limited
Dr. Morepen Limited has 13 board changes on record since 2007: 4 appointments and 9 cessations. The latest: Aakriti Suri was appointed as Additional Director on 14 Nov 2025.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Dr. Morepen Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dr. Morepen Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dr. Morepen Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dr. Morepen Limited
Dr. Morepen has 18 GST registrations: 14 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCD4166G1ZT | Delhi | Active | 01 Jul 2017 |
| 10AABCD4166G1Z6 | Bihar | Active | 01 Jul 2017 |
| 18AABCD4166G1ZQ | Assam | Active | 01 Jul 2017 |
| 19AABCD4166G1ZO | West Bengal | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dr. Morepen Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Dr. Morepen Limited
Frequently Asked Questions about Dr. Morepen Limited
Dr. Morepen is an active public limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 11 July 2001 (25+ years old) and is registered under CIN U24232DL2001PLC111636.
Dr. Morepen reported revenue of ₹170.92 Cr for FY 2025 (up 81% YoY).
Dr. Morepen has 4 current directors:
- Varun Suri - Managing Director
- Aakriti Suri - Additional Director
- Sharad Jain - Director
- Ranjit Khattar - Director
Dr. Morepen reported a net profit of ₹10.01 Cr (net margin 5.9%) and EBITDA of ₹14.87 Cr (EBITDA margin 8.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dr. Morepen is 17% over three years and 21% over five years. In the latest year (FY 2025) revenue rose 81%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dr. Morepen is 07AABCD4166G1ZT, registered in Delhi. The company has 18 GST registrations in all, of which 14 are active and 4 are cancelled or inactive. Other active GSTINs include 10AABCD4166G1Z6 (Bihar), 18AABCD4166G1ZQ (Assam), 19AABCD4166G1ZO (West Bengal).
The CIN (Corporate Identification Number) of Dr. Morepen is U24232DL2001PLC111636. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr. Morepen has 209 court cases on record: 182 filed by the company and 25 filed against it. 62 are pending. Most are in the district courts.
Dr. Morepen was incorporated on 11 July 2001, making it 25+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Dr. Morepen by revenue are Anzen Exports Private Limited, Dhanvanthri Speciality Pharma Private Limited, Medsource Healthcare Private Limited, Farmachem Life Private Limited, Goa Medicos Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution).
Aakriti Suri was appointed as Additional Director on 14 Nov 2025. Ajay Kumar Sharma ceased to be Director on 31 Jul 2025. Bhupender Raj Wadhwa ceased to be Director on 28 Sep 2024. Dr. Morepen has 13 board changes on record in total.